Can 101 Carry the Weight
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by:Jacob R. Rosenbaum and Justin K. Theam
POWERBLOCK HOLDING, INC. v. IFIT, INC.
Before Taranto, Stoll, and District Judge Scarsi. Appeal from the United States District Court for the District of Utah.
Summary: Under step one of the Alice test, claims should be considered in their entirety to ascertain whether their character as a whole is directed to excluded subject matter.
PowerBlock Holdings (PowerBlock) sued iFit for patent infringement and unfair competition. iFit filed a motion to dismiss under 35 U.S.C. § 101, arguing that the claims were directed to the abstract idea of automated weight stacking. iFit argued that the patent claimed a weight selection and adjustment system consisting of generic components, without adding significantly more to the abstract idea. The district court agreed, found all but one claim ineligible under § 101, and granted iFit’s motion to dismiss. PowerBlock appealed.
The Federal Circuit reversed, holding that the claims at issue were not directed to an abstract idea under step one of the Alice test. The court held that the claims recited meaningful structural limitations, not just generic components, that provided a specific implementation of automatic weight stacking. Further, the Federal Circuit rejected iFit’s attempts to read out or ignore limitations merely because they could be found in the prior art, because step one of Alice should involve consideration of the claims in their entirety to ascertain whether their character as a whole is directed to excluded subject matter. Failing to do so can improperly conflate the separate novelty and obviousness inquires under 35 U.S.C. §§ 102 and 103 with the eligibility inquiry under § 101. Accordingly, the Federal Circuit reversed and remanded.
Editor: Sean Murray
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…